Literature DB >> 11813813

CT of airways disease and bronchiectasis.

Georgeann McGuinness1, David P Naidich.   

Abstract

High-resolution CT is accepted as an accurate noninvasive means of diagnosing bronchiectasis. A wide spectrum of abnormalities may be identified at HRCT in patients with airway disease, including various distinctive patterns of bronchiectasis in specific clinical settings, such as ABPA, MAC infection, AIDS, and CF. Characteristic CT findings occasionally suggest a specific diagnosis that may not have been under clinical consideration. HRCT also provides significant clinical use in assessing the degree and extent of airway disease, and allows noninvasive monitoring of disease progression, regression, or response to therapy.

Entities:  

Mesh:

Year:  2002        PMID: 11813813     DOI: 10.1016/s0033-8389(03)00105-2

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  28 in total

1.  Is limited computed tomography the future for imaging the lungs of children with cystic fibrosis?

Authors:  S C Langton Hewer
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

2.  Assessing immune function in adult bronchiectasis.

Authors:  P T King; P Hutchinson; P W Holmes; N J Freezer; V Bennett-Wood; R Robins-Browne; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

3.  Systemic humoral immunity to non-typeable Haemophilus influenzae.

Authors:  P T King; J Ngui; D Gunawardena; P W Holmes; M W Farmer; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

4.  Quantitative CT Measures of Bronchiectasis in Smokers.

Authors:  Alejandro A Diaz; Thomas P Young; Diego J Maselli; Carlos H Martinez; Ritu Gill; Pietro Nardelli; Wei Wang; Gregory L Kinney; John E Hokanson; George R Washko; Raul San Jose Estepar
Journal:  Chest       Date:  2016-11-24       Impact factor: 9.410

Review 5.  Inhaled Antibiotics for Gram-Negative Respiratory Infections.

Authors:  Eric Wenzler; Dustin R Fraidenburg; Tonya Scardina; Larry H Danziger
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

6.  Lobar distribution in non-cystic fibrosis bronchiectasis predicts bacteriologic pathogen treatment.

Authors:  S Izhakian; W G Wasser; L Fuks; B Vainshelboim; B D Fox; O Fruchter; M R Kramer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-12       Impact factor: 3.267

Review 7.  [Nontuberculous mycobacteria in sputum : Recommendations for diagnosis and treatment].

Authors:  J Rademacher
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

8.  Noninvasive and invasive ventilation in acute respiratory failure associated with bronchiectasis.

Authors:  Jason Phua; Yvonne L E Ang; Kay Choong See; Amartya Mukhopadhyay; Erlinda A Santiago; Eleanor G Dela Pena; Tow Keang Lim
Journal:  Intensive Care Med       Date:  2010-01-06       Impact factor: 17.440

9.  A neglected problem of developing countries: Noncystic fibrosis bronchiectasis.

Authors:  Arzu Babayigit; Duygu Olmez; Nevin Uzuner; Handan Cakmakci; Tuba Tuncel; Ozkan Karaman
Journal:  Ann Thorac Med       Date:  2009-01       Impact factor: 2.219

Review 10.  The pathophysiology of bronchiectasis.

Authors:  Paul T King
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.